Alamar Capital Management, LLC Outlook Therapeutics, Inc. Transaction History

Alamar Capital Management, LLC

  • $126 Million
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 21, 2023
SELL
$0.87 - $1.33 $3,045 - $4,655
-3,500 Reduced 14.89%
20,000 $21,000
Q3 2022

Nov 18, 2022
BUY
$1.02 - $1.26 $3,570 - $4,410
3,500 Added 17.5%
23,500 $29,000
Q4 2021

Feb 10, 2022
BUY
$1.27 - $2.23 $25,400 - $44,600
20,000 New
20,000 $27,000

Others Institutions Holding OTLK

# of Institutions
7
Shares Held
67.1K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.6B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Alamar Capital Management, LLC Portfolio

Follow Alamar Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alamar Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alamar Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email